CIAM
PCRX icon

Caitong International Asset Management’s Pacira BioSciences PCRX Stock Holding History

Caitong International Asset Management’s Portfolio PCRX Stock Details PCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-9
Closed -$203 – 3349
2026
Q1 		$203 Buy
+9
New +$200 ﹤0.01% 1878
2025
Q4 		– Sell
-52
Closed -$1.34K – 2264
2025
Q3 		$1.34K Sell
52
-1
-2% -$25 ﹤0.01% 1424
2025
Q2 		$1.27K Sell
53
-1,991
-97% -$50.2K ﹤0.01% 1520
2025
Q1 		$50.8K Buy
+2,044
New +$48.9K 0.04% 492

Other funds holding PCRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DPCM
Doma Perpetual Capital Management Miami, Florida $431M AUM 13.21% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Caitong International Asset Management's PCRX Position: Q2 2026 in Review

Caitong International Asset Management sold out of Pacira BioSciences (PCRX) in Q2 2026, closing a stake of 9 shares — an estimated $203 sold.

Caitong International Asset Management first reported a position in PCRX in Q1 2025 and held it in 4 quarters. The position peaked at $50.8K in Q1 2025. 253 funds tracked by Wall St. Rank hold PCRX as of Q2 2026.

  • Caitong International Asset Management reported no remaining Pacira BioSciences position as of Q2 2026 after selling out during the quarter.
  • Caitong International Asset Management sold 9 Pacira BioSciences shares in Q2 2026, an estimated $203.
  • Caitong International Asset Management first reported a position in Pacira BioSciences in Q1 2025 and held it in 4 quarters.
  • Caitong International Asset Management's Pacira BioSciences position peaked at $50.8K in Q1 2025.
  • 253 funds tracked by Wall St. Rank held Pacira BioSciences as of Q2 2026.

Based on Caitong International Asset Management's 13F filing for Q2 2026, filed 5 Aug 2026.